Sempre Health and Novo Nordisk Partner to Improve Medication Costs for Patients With Diabetes Read more
Synlogic Doses First Subject in Phase 1/2a Trial of SYNB1618 for Treatment of Phenylketonuria Read more
ProBioGen Signs Second Contract Development Agreement with Tizona Therapeutics for Immuno-Oncology Antibody Project Read more
Novartis renews commitment to malaria elimination, investing USD 100 million to research and develop next-generation antimalarials Read more
Merck Announces First Phase Three Studies for PCV-15 (V114) Its Investigational Pneumococcal Disease Vaccine Read more